Stem cells have great potential for prevention, rejuvenation, healing and therapy. Our goal is to make this promise a reality and to manufacture the safest and most efficient stem cell drugs for selected medical applications as well as for research. 

Pharmicell Europe GmbH was founded in Berlin in 2006 to develop adult stem cell therapies. It is the European subsidiary of FCB Pharmicell Co. Ltd., based in South Korea. Pharmicell Europe’s R&D laboratories are located in the Center of Berlin and in the Europarc Dreilinden commercial area in the state of Brandenburg (approximately 30 minutes commute from Berlin’s city center). The Europarc facility also hosts Pharmicell’s cell production area.

The cell production facility consists of high-end cleanroom laboratories for the production of cell based therapeutics under GMP conditions.